STEC, Unspecified
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS (NCT04132375) | Inmunova S.A. | 2019-07-17 |
Track STEC, Unspecified automatically
Every clearance here is in the API, with alerts when new ones post.